Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Paz

Showing results (141-150 of 258) with videos related to

Pageof 26
Sort By:
Toxicology and Applied Pharmacology|December 11, 2013
Time course of systemic oxidative stress and inflammatory response induced by an acute exposure to Residual Oil Fly AshT Marchini, N D Magnani, M L Paz, et al.
Carbohydrate Research|June 5, 2020
Chemical and physical properties of nanocrystalline chitosan by the method: Modified nanochitosan complex and process of obtaining modified nanochitosanM F Guimarães, L Pighinelli, R L Paz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 1998
A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancerD Castellano, P Lianes, L Paz-Ares, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2016
Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICsP Gagetti, F Pasteran, M P Martinez, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2000
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancerJ Bellmunt, V Guillem, L Paz-Ares, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up dataD Cunningham, L Paz-Ares, M E Gore, et al.
Respiration; International Review of Thoracic Diseases|December 11, 2003
Abnormalities of the respiratory function and control of ventilation in patients with anorexia nervosaJ M R González-Moro, J De Miguel-Díez, L Paz-González, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|September 14, 2013
New hosts of Myrothecium SPP. In brazil and a preliminary In Vitro assay of fungicidesA M Quezado Duval, G P Henz, M L Paz-Lima, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancerF Caponigro, C Dittrich, J B Sorensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2016
Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancerL Paz-Ares, M A Socinski, J Shahidi, et al.
Pageof 26

Showing results (141-150 of 258) with videos related to

Sort By:
Pageof 26
Toxicology and Applied Pharmacology|December 11, 2013
Time course of systemic oxidative stress and inflammatory response induced by an acute exposure to Residual Oil Fly AshT Marchini, N D Magnani, M L Paz, et al.
Carbohydrate Research|June 5, 2020
Chemical and physical properties of nanocrystalline chitosan by the method: Modified nanochitosan complex and process of obtaining modified nanochitosanM F Guimarães, L Pighinelli, R L Paz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 1998
A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancerD Castellano, P Lianes, L Paz-Ares, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2016
Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICsP Gagetti, F Pasteran, M P Martinez, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2000
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancerJ Bellmunt, V Guillem, L Paz-Ares, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up dataD Cunningham, L Paz-Ares, M E Gore, et al.
Respiration; International Review of Thoracic Diseases|December 11, 2003
Abnormalities of the respiratory function and control of ventilation in patients with anorexia nervosaJ M R González-Moro, J De Miguel-Díez, L Paz-González, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|September 14, 2013
New hosts of Myrothecium SPP. In brazil and a preliminary In Vitro assay of fungicidesA M Quezado Duval, G P Henz, M L Paz-Lima, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancerF Caponigro, C Dittrich, J B Sorensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2016
Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancerL Paz-Ares, M A Socinski, J Shahidi, et al.
Pageof 26